Raymond James Financial Services Advisors, Inc. - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 31 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$13,000
-53.6%
48,6410.0%0.00%
Q2 2022$28,000
-3.4%
48,641
+11.5%
0.00%
Q1 2022$29,000
-38.3%
43,6410.0%0.00%
Q4 2021$47,000
-17.5%
43,6410.0%0.00%
Q3 2021$57,000
-34.5%
43,6410.0%0.00%
Q2 2021$87,000
-26.3%
43,6410.0%0.00%
Q1 2021$118,00043,6410.00%
Other shareholders

There were no reported owners of QUALIGEN THERAPEUTICS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of QUALIGEN THERAPEUTICS INC shareholders